http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2328725-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-24 |
| filingDate | 2002-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94f4814ef02d5431a14c211071834e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8675a5b700f5e4d9adec64ab47a33b9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_512f45e62e4725461c274c08e8c67b44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4409f5a0cc8517c1439260acdc0a3da7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6dd90114c5b69fc2bf92738e240c55c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1a8dc4267eb626aae56dc946f974ce8 |
| publicationDate | 2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2328725-T3 |
| titleOfInvention | DERIVATIVES OF PHENYLPIRIDINE AS INHIBITORS OF SEROTONINE REABSORTION. |
| abstract | A compound represented by the general formula I ** (See formula) ** in which: Y is C or CH; X represents S; m is 1 or 2; p is 0, 1, 2, 3, 4, 5, 6, 7 or 8; q is 0, 1, 2, 3 or 4; s is 0, 1, 2, 3, 4 or 5; the dotted line represents an optional link; Each R1 is independently selected from the group represented by C1-6 alkyl, or two R1 attached to the same carbon atom can form a 3-6 membered spirally linked cycloalkyl; Each R2 is independently selected from the groups represented by halogen, cyano, nitro, alkyl (en / in) C1-6 yl, alkyl (en / in) C1-6 yloxy, alkyl (en / in) il-C1 - 6- sulfanyl, hydroxy, hydroxy-alkyl (en / in) C1-6 yl, halo-alkyl (en / in) C1-6 yl, halo-alkyl (en / in) C1-6 yloxy, cycloalkyl (en) C3-yl 8, cycloalkyl (en) yl-C3-8-alkyl (en / in) C1-6 yl, acyl, alky (in / in) C1-6-yloxy-C1-6-alkyloxy -sulfonyl, or -NR x R y; -NR x CO-alkyl (en / in) C1-6 yl; Each R3 is independently selected from a group represented by halogen, cyano, nitro, alkyl (en / in) C1-6 yl, alkyl (en / in) C1-6 yloxy, alkyl (en / in) il-C1 - 6- sulfanyl, hydroxy, hydroxy-alkyl (en / in) C1-6 yl, halo-alkyl (en / in) C1-6 yl, halo-alkyl (en / in) C1-6 yloxy, cycloalkyl (en) C3-yl 8, cycloalkyl (en) yl-C3-8-alky (en / in) C1-6 yl, alky (en / in) yl-C1-6-sulfonyl, aryl, alkylo (en / in) iloxy-C1-6 -carbonyl, acyl, -NR x CO-alkyl (en / in) C1-6 yl, CONR x R y or NR x R y; or two adjacent R3 substituents form together a heterocycle fused to the phenyl ring selected from the group consisting of ** (See formula) ** in which W is O or S, and R '' and R "are hydrogen or C1 alkyl - 6; or two adjacent R 3 substituents form together a condensed heteroaromatic system containing one, two or three heteroatoms, wherein each R x and R and is independently selected from the group represented by hydrogen, C1 (in / in) C1-yl 6, cycloalkyl (en / in) C3-8 yl, cycloalkyl (en / in) il-C3-8-alkyl (en / in) C1-6 yl, or aryl; or R x and R and together with the nitrogen to which they are joined form a 3-7 member ring that optionally contains another heteroatom; or a pharmaceutically acceptable acid addition salt thereof for use as a medicine. |
| priorityDate | 2001-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 273.